Literature DB >> 25983661

ALCAM: Basis Sequence: Mouse.

Amanda G Hansen1, Guido W Swart2, Andries Zijlstra1.   

Abstract

Entities:  

Year:  2011        PMID： 25983661      PMCID： PMC4432864          DOI： 10.1038/mp.a004126.01

Source DB:  PubMed          Journal:  AFCS Nat Mol Pages        ISSN： 1477-5921


× No keyword cloud information.
  86 in total

1.  ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.

Authors:  Simon Davies; Wen G Jiang
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

2.  Monoclonal antibodies reactive with human osteogenic cell surface antigens.

Authors:  S P Bruder; M C Horowitz; J D Mosca; S E Haynesworth
Journal:  Bone       Date:  1997-09       Impact factor: 4.398

3.  STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro.

Authors:  Karina Stewart; Peter Monk; Susan Walsh; Carolyn M Jefferiss; Julie Letchford; Jon N Beresford
Journal:  Cell Tissue Res       Date:  2003-07-22       Impact factor: 5.249

4.  Relevance of CD6-mediated interactions in T cell activation and proliferation.

Authors:  Idoia Gimferrer; Maria Calvo; María Mittelbrunn; Montse Farnós; Maria Rosa Sarrias; Carlos Enrich; Jordi Vives; Francisco Sánchez-Madrid; Francisco Lozano
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

5.  Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA).

Authors:  Shiaw-Lin Wu; Jeongkwon Kim; Russell W Bandle; Lance Liotta; Emanuel Petricoin; Barry L Karger
Journal:  Mol Cell Proteomics       Date:  2006-06-23       Impact factor: 5.911

6.  Culture and characterization of human bone marrow mesenchymal stem cells.

Authors:  Bruno Delorme; Pierre Charbord
Journal:  Methods Mol Med       Date:  2007

7.  Different subcellular localization of ALCAM molecules in neuroblastoma: Association with relapse.

Authors:  Maria Valeria Corrias; Claudio Gambini; Andrea Gregorio; Michela Croce; Gaia Barisione; Claudia Cossu; Armando Rossello; Silvano Ferrini; Marina Fabbi
Journal:  Cell Oncol       Date:  2010       Impact factor: 6.730

8.  ALCAM (CD166): its role in hematopoietic and endothelial development.

Authors:  O Ohneda; K Ohneda; F Arai; J Lee; T Miyamoto; Y Fukushima; D Dowbenko; L A Lasky; T Suda
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

9.  BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems.

Authors:  O Pourquié; C Corbel; J P Le Caer; J Rossier; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

10.  Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.

Authors:  C Kahlert; H Weber; C Mogler; F Bergmann; P Schirmacher; H G Kenngott; U Matterne; N Mollberg; N N Rahbari; U Hinz; M Koch; M Aigner; J Weitz
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640
View more
  7 in total

1.  Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

Authors:  Amanda G Hansen; Tanner J Freeman; Shanna A Arnold; Alina Starchenko; Celestial R Jones-Paris; Michael A Gilger; Mary K Washington; Kang-Hsien Fan; Yu Shyr; Robert D Beauchamp; Andries Zijlstra
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

Review 2.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

3.  ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.

Authors:  Amanda G Hansen; Shanna A Arnold; Ming Jiang; Trenis D Palmer; Tatiana Ketova; Alyssa Merkel; Michael Pickup; Susan Samaras; Yu Shyr; Harold L Moses; Simon W Hayward; Julie A Sterling; Andries Zijlstra
Journal:  Cancer Res       Date:  2014-01-02       Impact factor: 12.701

Review 4.  Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.

Authors:  Chao Ni; Zhigang Zhang; Xiaotao Zhu; Yang Liu; Dihong Qu; Ping Wu; Jian Huang; A-xiang Xu
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 5.  Cell Adhesion Molecules and Ubiquitination-Functions and Significance.

Authors:  Mirka Homrich; Ingo Gotthard; Hilke Wobst; Simone Diestel
Journal:  Biology (Basel)       Date:  2015-12-23

6.  Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer.

Authors:  Yeqing Zhang; Chunmei Qian; Lin Jing; Jianlin Ren; Yu Guan
Journal:  Oncotarget       Date:  2017-07-18

7.  Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis.

Authors:  Susu Han; Wei Yang; Shaoqi Zong; Hongjia Li; Shanshan Liu; Wen Li; Qi Shi; Fenggang Hou
Journal:  Oncotarget       Date:  2017-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.